The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The study objective is to evaluate the safety and effectiveness of different doses of
Metacavir Enteric-coated Capsules in treatment of chronic hepatitis B,as well as to find an
appropriate clinical dosage by comparing the effect of different doses of treatment,in order
to provide references of clinical trial of the next phase.